CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,302,000 | -85.5% | 71,010 | -88.2% | 0.01% | -91.8% |
Q2 2020 | $9,007,000 | +42.5% | 601,653 | +50.6% | 0.10% | -38.6% |
Q1 2020 | $6,322,000 | -5.5% | 399,632 | -3.0% | 0.16% | -6.5% |
Q4 2019 | $6,689,000 | +28.8% | 411,880 | +17.8% | 0.17% | +49.6% |
Q3 2019 | $5,195,000 | -0.0% | 349,625 | +11.2% | 0.11% | -13.7% |
Q2 2019 | $5,197,000 | +5.1% | 314,378 | +10.0% | 0.13% | -7.1% |
Q1 2019 | $4,944,000 | – | 285,762 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|